ANA GAVIRIA: Open Payments
NPI 1649688979 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$618 in 22 payments from 11 companies in 2025. Trend: 2023 $417 · 2024 $486 · 2025 $618
Food & beverage: $587Education: $31
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 2 | $154 |
| PFIZER INC. | 5 | $112 |
| TerSera Therapeutics LLC | 2 | $69 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Lilly USA, LLC | 3 | $55 |
| Genentech USA, Inc. | 2 | $50 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Stemline Therapeutics Inc. | 1 | $23 |
| Caris MPI, Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
Products named: ENHERTU, IBRANCE, Zoladex, KEYTRUDA, VERZENIO, Itovebi, TIVDAK, Orserdu.
Industry payments across FL — which companies pay providers there.
